Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Stabilisation Notice

2 Nov 2018 17:39

RNS Number : 2580G
Goldman Sachs International
02 November 2018
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Notice relating to stabilization transactions pursuant to article 5(4) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 as well as article 6(2), (3) and article 8 of Commission Delegated Regulation (EU) No 2016/1052 of 8 March 2016

Aston Martin Lagonda Global Holdings plc

Stabilisation Notice

2 November 2018

Goldman Sachs International, acting as the Stabilization Manager in connection with the initial public offering of Aston Martin Lagonda Holdings plc (the "Company"), has today informed the Company that the following stabilization measures were carried out during the stabilization period from 03 October 2018 until 02 November 2018 in relation to the ordinary shares of Aston Martin Holdings plc (ISIN GB00BFXZC448), which started trading on the London Stock Exchange on 03 October 2018:

Execution Date

Lowest Price in GBP

Highest Price in GBP

Trading Venue

03 October 2018

17.75

19

LNSE

04 October 2018

17.6

18

LNSE

05 October 2018

17.45

17.55

LNSE

08 October 2018

15.76

16.55

LNSE

09 October 2018

15.94

16.374

LNSE

10 October 2018

15.72

16.1

LNSE

11 October 2018

14.754

16.196

LNSE

12 October 2018

15.094

15.55

LNSE

15 October 2018

14.76

15.5

LNSE

16 October 2018

14.214

15.886

LNSE

17 October 2018

14.706

15.88

LNSE

18 October 2018

14.484

15.002

LNSE

19 October 2018

14.288

14.7

LNSE

22 October 2018

14.354

14.712

LNSE

23 October 2018

13.89

14.35

LNSE

24 October 2018

13.714

14.316

LNSE

25 October 2018

13.802

14.356

LNSE

26 October 2018

14.062

14.498

LNSE

29 October 2018

14.018

14.502

LNSE

30 October 2018

14.15

15.232

LNSE

31 October 2018

15.006

15.59

LNSE

01 November 2018

14.756

15.576

LNSE

 

Disclaimer

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of Aston Martin Lagonda Holdings plc in any jurisdiction.

This announcement is not an offer of securities for sale in the United States. The securities referred to above have not been, and will not be, registered under the U. S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAUGGAWGUPRGMP
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.